Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn
Wall Street has come down crashing on President Donald Trump’s sweeping tariffs, raising the risk of a trade war that could push the global economy into recession.
Gain Therapeutics Inc. (GANX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Gotham Asset Management Joel Greenblatt | 158,155 | $3,737,203 | -53% | 0.03% |
| 2. | Greenlight Capital David Einhorn | 566,130 | $1,222,841 | 0.06% | |
| 3. | Marshall Wace LLP Paul Marshall And Ian Wace | 91,738 | $198,155 | 0% | |
| 4. | Springbok Capital Gavin Saitowitz And Cisco J. Del Valle | 35,820 | $77,371 | 0% | |
| 5. | Sprott Asset Management Eric Sprott | 14,000 | $30,240 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.01 | 14,400 | Officer | 14,400 | 2024-08-09 | Filing | |
| $1.00 | 50,000 | Officer, Director | 50,000 | 2024-08-09 | Filing | |
| $1.21 | 12,000 | Director | 289,629 | 2024-07-01 | Filing | |
| $1.23 | 5,000 | Director | 277,629 | 2024-07-01 | Filing | |
| $3.86 | 30,000 | Director | 30,000 | 2024-03-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.46 | 206 | Officer, Director | 5,286 | 2023-12-21 | Filing | |
| $2.50 | 1,820 | Officer, Director | 4,855 | 2023-12-07 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 254,990 | $487,031 | 0% | |
| 2. | 125,584 | $239,865 | 0.28% | |
| 3. | 84,407 | $161,218 | 0% | |
| 4. | 18,000 | $34,380 | 0.01% | |
| 5. | 10,750 | $22,038 | 0% |
News See All
Insiders are Piling into These 10 Healthcare Stocks in 2024
In this article, we will take a detailed look at Insiders are Piling into These 10 Healthcare Stocks in 2024. For a quick overview of such stocks, read our article Insiders are Piling into These 5 ...
Insiders Are Buying These 5 Penny Stocks
Maryland-based biotechnology company Gain Therapeutics Inc (NASDAQ:GANX) ranks fifth in our list of the penny stocks with latest insider purchases.
Billionaire David Einhorn's 5 Stock Picks with Huge Upside Potential
In this article, we will take a look at billionaire David Einhorn’s 5 stock picks with huge upside potential.
Is Gain Therapeutics, Inc. (GANX) A Good Stock To Buy?
In this article we will analyze whether Gain Therapeutics, Inc.
Billionaire Hedge Funds
